drugset / Trial / NCT04096716

Mapping Draining Lymph Nodes in CNS Malignancies

NCT04096716

Non-randomizedParallel-groupOpen-labelDiagnostic

Summary

The purpose of this research study is to determine whether the lymph nodes that drain a brain tumor can be detected by imaging after injection of a substance called Tc-99m tilmanocept directly into the brain tissue around the tumor. Tc-99m tilmanocept is a radioactive substance that is used to find lymph nodes by injecting it and then scanning the body with a device that can trace its radioactivity. In this study, the investigators are looking to see how long it takes the Tc-99m tilmanocept to travel from the tumor to the lymph nodes. The investigators will be using it to map lymph nodes as they relate to specific brain areas.

Timeline

Start
2019-12-03
Primary completion
2022-04-30
Completion
2022-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Technetium Tc 99m Tilmanocept Diagnostic / imaging agent 0.3 ml Other
Subject Technetium Tc 99m Tilmanocept Diagnostic / imaging agent 0.5 ml Other